FindTrial
Sign In

Based on AI-generated exercise prescriptions combined with Chu needle therapy for personalized treatment optimization and efficacy research in knee osteoarthritis

Research on optimization of personalized protocols and therapeutic efficacy of AI-empowered integrated traditional Chinese and Western medicine treatment for KOA through observation of differences in Visual Analog Scale (VAS) scores, WOMAC scores, inflammatory markers and other indicators before and after intervention.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001374
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-06-20
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Experimental Group:Conventional treatment combined with Chu needle therapy and AI-generated exercise prescription
Control Group 1:Conventional treatment
Control Group 2:Conventional treatment combined with Chu needle therapy

Sponsors

Deyang Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age 40-75 years, diagnosed with early to moderate KOA (Kellgren-Lawrence grade I-III); (2) Presence of knee pain (VAS =4) and dysfunction (WOMAC total score =25); (3) No severe cardiovascular/cerebrovascular diseases or exercise contraindications.

Exclusion criteria

Exclusion criteria: (1) Recent knee surgery or intra-articular injection therapy; (2) Recent acupuncture treatment; (3) Recent use of non-steroidal anti-inflammatory drugs; (4) Comorbid secondary joint diseases such as rheumatoid arthritis or gouty arthritis; (5) Patients with deep vein thrombosis; (6) Patients with significant knee effusion or varus/valgus deformity.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) score;Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score;—

Secondary

MeasureTime frame
World Health Organization Quality of Life Scale (WHOQOL);Serum interleukin-6;Tumor Necrosis Factor-alpha;Get Up and Go Test;—

Countries

China

Contacts

Public ContactJun Qiu

Deyang Affiliated Hospital of Chengdu University of Traditional Chinese Medicine

qiujun_hospital@163.com13881070630

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026